EP Patent

EP2206497A1 — Polymorphic form of atorvastatin calcium

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2010-07-14 · 16y expired

What this patent protects

The present invention relates to pharmaceutical compositions and dosage forms containing atorvastatin calcium Form V.

USPTO Abstract

The present invention relates to pharmaceutical compositions and dosage forms containing atorvastatin calcium Form V.

Drugs covered by this patent

vadadustat (VADADUSTAT)

Patent Metadata

Patent number: EP2206497A1
Jurisdiction: EP
Classification: —
Expires: 2010-07-14
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.